15847-24-2 (泼尼松龙杂质 标准品,20(R)-Hydroxy Prednisolone)

20(R)-羟基泼尼松龙;泼尼松龙杂质 标准品;

20β-Hydroxy Prednisolone;20(R)-Hydroxy Prednisolone;(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;(20αH)-20-Dihydroprednisolone;(20R)-11β,17,20,21-Tetrahydroxypregna-1,4-dien-3-one;(20R)-11β,17α,20,21-Tetrahydroxypregna-1,4-dien-3-one;20β-Hydroxyprednisolone;(20R)-Hydroxyprednisolone;20alpha-Dihydro-prednisolone (M-III);15847-24-2;SCHEMBL10614309;Pregna-1,4-dien-3-one, 11beta,17,20beta,21-tetrahydroxy-;J-009503;20beta-dihydro-PRED;DTXSID30553372;PD094311;(20R)-11beta,17alpha,20,21-Tetrahydroxypregna-1,4-dien-3-one;(11beta,20R)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one;6R8UWB66L3;CHEBI:180696;M-II in PMID 25800201;Pregna-1,4-dien-11beta,17alpha,20beta,21-tetrol-3-one;Pregna-1,4-dien-3-one, 11,17,20,21-tetrahydroxy-, (11beta,20R)-;11beta,17,20beta,21-Tetrahydroxy-1,4-pregnadien-3-one;

LCOVYWIXMAJCDS-LCGKLAOVSA-N

1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-18,22,24-26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,17+,18+,19-,20-,21-/m0/s1

O[C@]1([C@@H](CO)O)CC[C@H]2[C@@H]3CCC4=CC(C=C[C@]4(C)[C@H]3[C@H](C[C@@]21C)O)=O